Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.
Saved in:
| Title: | Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis. |
|---|---|
| Authors: | Cardner M; Novartis Pharma AG, Basel, Switzerland.; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tuckwell D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Kostikova A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Forrer P; Novartis Pharma AG, Basel, Switzerland., Siegel RM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Marti A; Novartis Pharma AG, Basel, Switzerland., Vandemeulebroecke M; Novartis Pharma AG, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com., Ferrero E; Novartis Institutes for BioMedical Research, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com. |
| Source: | RMD open [RMD Open] 2023 Jun; Vol. 9 (2). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2056-5933 |
|---|---|
| DOI: | 10.1136/rmdopen-2023-003042 |
